| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,270,000 |
| Market
Cap: |
279.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.29 - $37.61 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.1 |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 16.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
30,000 |
30,000 |
30,000 |
30,000 |
| Total Buy Value |
$209,400 |
$209,400 |
$209,400 |
$209,400 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
29,089 |
29,089 |
295,146 |
446,160 |
| Total Sell Value |
$143,717 |
$143,717 |
$8,000,388 |
$12,719,522 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
4 |
4 |
18 |
27 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Allouche Cyril |
Principal Financial Officer |
• – – |
2018-07-06 |
4 |
AS |
$28.35 |
$11,142 |
D/D |
(393) |
4,750 |
|
- |
|
| Allouche Cyril |
Principal Financial Officer |
• – – |
2018-06-29 |
4 |
A |
$23.33 |
$9,170 |
D/D |
393 |
5,143 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2018-06-29 |
4 |
A |
$23.33 |
$15,586 |
D/D |
668 |
142,543 |
|
- |
|
| Allouche Cyril |
Principal Financial Officer |
• – – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
250 |
4,750 |
|
- |
|
| Silvernail Lauren P |
CFO & CBO |
• – – |
2018-05-22 |
4 |
AS |
$30.25 |
$86,924 |
D/D |
(2,874) |
65,497 |
|
- |
|
| Vickers Philip J. |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,150 |
|
- |
|
| Russell Angus C. |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
|
- |
|
| Gangolli Julian S |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
|
- |
|
| Byrnes Robert F |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
|
- |
|
| Foley Mark J |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
|
- |
|
| Mcdowell Caryn Gordon |
SVP, GC & Secretary |
• – – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
16,000 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2018-03-22 |
4 |
AS |
$30.85 |
$105,839 |
D/D |
(3,431) |
68,371 |
|
- |
|
| Joshi Abhay |
Chief Operating Officer |
• – – |
2018-03-21 |
4 |
OE |
$2.55 |
$1,698 |
D/D |
666 |
84,263 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2018-03-16 |
4 |
S |
$31.51 |
$168,045 |
D/D |
(5,333) |
3,000 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2018-03-16 |
4 |
OE |
$2.55 |
$13,599 |
D/D |
5,333 |
8,333 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2018-03-16 |
4 |
AS |
$31.43 |
$171,348 |
D/D |
(5,452) |
141,875 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2018-03-16 |
4 |
OE |
$2.55 |
$51,000 |
D/D |
20,000 |
147,327 |
|
- |
|
| Vickers Philip J. |
Director |
– • – |
2018-03-16 |
4 |
B |
$31.20 |
$98,393 |
D/D |
3,150 |
6,150 |
2.39 |
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2018-03-15 |
4 |
D |
$31.65 |
$91,184 |
D/D |
(2,881) |
127,327 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2018-03-15 |
4 |
AS |
$32.80 |
$32,800 |
D/D |
(1,000) |
130,208 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2018-03-15 |
4 |
D |
$31.65 |
$36,461 |
D/D |
(1,152) |
71,802 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2018-03-13 |
4 |
AS |
$34.50 |
$892,412 |
D/D |
(25,867) |
72,954 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2018-03-13 |
4 |
OE |
$8.70 |
$225,043 |
D/D |
25,867 |
98,821 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2018-03-09 |
4 |
AS |
$32.50 |
$325,000 |
D/D |
(10,000) |
72,954 |
|
- |
|
415 Records found
|
|
Page 10 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.11 (3.34%) 
